|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Leichsenring, Jonas; Vladimirova, Valentina; Solbach, Christine; Karn, Thomas; Ataseven, Beyhan; Sinn, Bruno Valentin; Barinoff, Jana; Mueller, Volkmar; Blohmer, Jens-Uwe; Schem, Christian; Engels, Knut; Marme, Frederik; Fisseler-Eckhoff, Annette; Fasching, Peter A.; Stickeler, Elmar; Mackelenbergh, Marion van; Denkert, Carsten; Stenzinger, Albrecht; Loibl, Sibylle und Groeschel, Stefan
(2022):
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
In: BMC Cancer, Bd. 22, Nr. 1, 1040
Jurmeister, Philipp; Weber, Karsten; Villegas, Sonia; Karn, Thomas; Untch, Michael; Thieme, Anne; Mueller, Volkmar; Taube, Eliane; Fasching, Peter; Schmitt, Wolfgang D.; Marme, Frederik; Stickeler, Elmar; Sinn, Bruno V.; Jank, Paul; Schem, Christian; Klauschen, Frederick; Mackelenbergh, Marion van; Denkert, Carsten; Loibl, Sibylle und Capper, David
(2021):
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.
In: Clinical Epigenetics, Bd. 13, Nr. 1, 184
Sinn, Bruno Valentin; Weber, Karsten E.; Schmitt, Wolfgang Daniel; Fasching, Peter A.; Symmans, William Fraser; Blohmer, Jens-Uwe; Karn, Thomas; Taube, Eliane Tabea; Klauschen, Frederick; Marme, Frederik; Schem, Christian; Stickeler, Elmar; Ataseven, Beyhan; Huober, Jens; Minckwitz, Gunter von; Seliger, Barbara; Denkert, Carsten und Loibl, Sibylle
(2019):
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
In: Breast Cancer Research, Bd. 21, Nr. 1, 142
Janning, Melanie; Müller, Volkmar; Vettorazzi, Eik; Cubas-Cordova, Miguel; Gensch, Victoria; Ben-Batalla, Isabel; Eulenburg, Christine zu; Schem, Christian; Fasching, Peter A.; Schnappauf, Benjamin; Karn, Thomas; Fehm, Tanja; Just, Marianne; Kühn, Thorsten; Holms, Frank; Overkamp, Friedrich; Krabisch, Petra; Rack, Brigitte; Denkert, Carsten; Untch, Michael; Tesch, Hans; Rezai, Mahdi; Kittel, Kornelia; Pantel, Klaus; Bokemeyer, Carsten; Loibl, Sibylle; Minckwitz, Gunter von und Loges, Sonja
(2019):
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
In: International Journal of Cancer, Bd. 145, Nr. 3: S. 857-868
Rody, Achim; Karn, Thomas; Liedtke, Cornelia; Pusztai, Lajos; Ruckhaeberle, Eugen; Hanker, Lars; Gaetje, Regine; Solbach, Christine; Ahr, Andre; Metzler, Dirk; Schmidt, Marcus; Mueller, Volkmar; Holtrich, Uwe und Kaufmann, Manfred
(2011):
A clinically relevant gene signature in triple negative and basal-like breast cancer.
In: Breast Cancer Research
13:R97
[PDF, 3MB]
Rody, Achim; Holtrich, Uwe; Pusztai, Laos; Liedtke, Cornelia; Gaetje, Regine; Ruckhaeberle, Eugen; Solbach, Christine; Hanker, Lars; Ahr, Andre; Metzler, Dirk; Engels, Knut; Karn, Thomas und Kaufmann, Manfred
(2009):
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
In: Breast Cancer Research
11:R15
[PDF, 2MB]